協合新能源(00182.HK)潛在出售三家附屬公司
協合新能源(00182.HK)公布,公司正在與一名有意向買方就出售公司之三間全資附屬公司100%股權進行磋商。目標附屬公司為於中國成立之有限公司,主要從事總裝機規模為196MW之三個風電項目之開發、建設及運營。
目前,目標附屬公司之未經審核資產淨值總額約為3.53億元人民幣(下同)。潛在出售事項之總代價預期約為4億元至4.5億元之間。於潛在出售事項完成後,集團將不再持有目標附屬公司之任何股權。
潛在出售之條款及條件仍在磋商當中,尚未訂立任何正式交易協議或其他具有法律約束力的協議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.